Early negative minimal residual disease in bone marrow after immunotherapy is less predictive of late or non-marrow relapse among patients with high-risk stage 4 neuroblastoma - Cheung, I Y; Feng, Y; Cheung, N K (Pediatr Blood Cancer, 2013)